Detail akcie China Medicine online

Business Summary: China Medicine Corporation is a pharmaceutical company. The Company is engaged in the production and distribution of prescription and over the counter (OTC) drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The Company is developing a number of products for a range of indications, including oncology, high blood pressure and the removal of toxins from food and animal feeds. The Company's products include Shuangdan Capsules, Houerhuan Anti-inflammatory Capsules, Shugan Yipi Granules, Danggui Tiaojing Granules, Huangzao Granules, Pingfeng Shengmai Capsules, Danqi Tablets and Naodesheng Tablets. The Company also offers a range of dietary supplements, which include BeThin Tablets, Refrelizer Herbal Tea, LifeFull Herbal Tea and Relaxetox Herbal Tea. Shuangdan Capsules are indicated for the treatment of stagnation of the heart blood, obstruction of qi in the chest and cardiodynia.
Financial Summary: BRIEF: For the nine months ended 30 September 2010, China Medicine Corporation revenues increased 2% to $45.3M. Net income applicable to common stockholders decreased 48% to $2M. Revenues reflect Proprietary products increase from $1.4M to $5.4M. Net income was offset by Research and development increase of 74% to $2M (expense), Other income (expense), net increase of 96% to $135K (expense).